TrialBMC cancer2024

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.

Irfan Cicin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.